Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies. This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9783725873463
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers L2-9783725873463
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers L2-9783725873463
Anzahl: Mehr als 20 verfügbar
Anbieter: California Books, Miami, FL, USA
Zustand: New. Bestandsnummer des Verkäufers I-9783725873463
Anzahl: Mehr als 20 verfügbar
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Hardcover. Zustand: new. Hardcover. Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9783725873463
Anzahl: 1 verfügbar
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Hardcover. Zustand: new. Hardcover. Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Bestandsnummer des Verkäufers 9783725873463
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Fungal infections represent a growing global health concern, particularly among immunocompromised patients. In recent decades, the emergence of antifungal resistance in clinically relevant fungi has increasingly limited the effectiveness of available therapies. At the same time, antifungal treatment options remain restricted to a small number of drug classes, highlighting the urgent need for new therapeutic strategies and a deeper understanding of resistance mechanisms. Antifungal resistance can arise through multiple biological processes, including mutations in drug targets, overexpression of efflux transporters, biofilm formation, and genetic or metabolic adaptations that allow fungal pathogens to survive antifungal pressure. Advances in molecular biology, genomics, and other experimental approaches have expanded our ability to investigate resistance mechanisms and identify potential targets for innovative antifungal therapies.This Reprint compiles recent advances in medical mycology focused on antifungal resistance and emerging therapeutic strategies. The contributions address molecular and genomic aspects of resistance, transcriptional responses to antifungal agents, identification of resistance-associated mutations, and the evaluation of novel antifungal compounds and repurposed drugs. Together, these studies provide an overview of current research aimed at understanding and overcoming antifungal resistance. Bestandsnummer des Verkäufers 9783725873463
Anzahl: 2 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Buch. Zustand: Neu. Multidrug-Resistant Fungi | Buch | Englisch | 2026 | MDPI AG | EAN 9783725873463 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. Bestandsnummer des Verkäufers 135244432
Anzahl: 5 verfügbar